Alkermes plc. (ALKS) stock
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30213% above fair value
$47.89+1.42 (+3.06%)
Close on Nov 11, 2026Market cap $8.03BP/E 126.0Yield –
Alkermes operating margin
Operating margin is operating income as a percentage of revenue.
Alkermes's operating margin for the twelve months ending Jun 30, 2026 was 7.0%. For fiscal 2025 it was 17.2%, against 27.0% the year before. The highest annual figure on record is 27.0% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.2% | −9.8 |
| FY2024 | Dec 31, 2024 | 27.0% | +2.1 |
| FY2023 | Dec 31, 2023 | 24.9% | +25.4 |
| FY2022 | Dec 31, 2022 | -0.5% | −8.9 |
| FY2021 | Dec 31, 2021 | 8.3% | +19.2 |
| FY2020 | Dec 31, 2020 | -10.8% | +4.2 |
| FY2019 | Dec 31, 2019 | -15.0% | −5.9 |
| FY2018 | Dec 31, 2018 | -9.1% | +7.3 |
| FY2017 | Dec 31, 2017 | -16.4% | +11.6 |
| FY2016 | Dec 31, 2016 | -28.0% | +7.7 |
| FY2015 | Dec 31, 2015 | -35.7% | −49.9 |
| FY2013 | Mar 31, 2013 | 14.2% | +36.9 |
| FY2012 | Mar 31, 2012 | -22.6% | +1.8 |
| FY2011 | Mar 31, 2011 | -24.4% | −0.3 |
| FY2010 | Mar 31, 2010 | -24.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 3.7% | −20.1 |
| Q1 FY2026 | Mar 31, 2026 | -12.3% | −16.8 |
| Q4 FY2025 | Dec 31, 2025 | 15.1% | −22.7 |
| Q3 FY2025 | Sep 30, 2025 | 22.6% | −5.1 |
| Q2 FY2025 | Jun 30, 2025 | 23.8% | −3.7 |
| Q1 FY2025 | Mar 31, 2025 | 4.5% | −7.9 |
| Q4 FY2024 | Dec 31, 2024 | 37.8% | +23.4 |
| Q3 FY2024 | Sep 30, 2024 | 27.7% | +4.3 |
| Q2 FY2024 | Jun 30, 2024 | 27.5% | −18.0 |
| Q1 FY2024 | Mar 31, 2024 | 12.4% | +16.2 |
| Q4 FY2023 | Dec 31, 2023 | 14.5% | −23.5 |
| Q3 FY2023 | Sep 30, 2023 | 23.4% | +47.4 |
| Q2 FY2023 | Jun 30, 2023 | 45.6% | +58.0 |
| Q1 FY2023 | Mar 31, 2023 | -3.8% | +5.7 |
| Q4 FY2022 | Dec 31, 2022 | 37.9% | −1.9 |
| Q3 FY2022 | Sep 30, 2022 | -24.0% | −17.3 |
| Q2 FY2022 | Jun 30, 2022 | -12.5% | −13.9 |
| Q1 FY2022 | Mar 31, 2022 | -9.5% | −3.0 |
| Q4 FY2021 | Dec 31, 2021 | 39.9% | +50.9 |
| Q3 FY2021 | Sep 30, 2021 | -6.7% | −2.7 |
| Q2 FY2021 | Jun 30, 2021 | 1.5% | +15.1 |
| Q1 FY2021 | Mar 31, 2021 | -6.5% | +8.6 |
| Q4 FY2020 | Dec 31, 2020 | -11.0% | −8.6 |
| Q3 FY2020 | Sep 30, 2020 | -4.0% | +17.0 |
| Q2 FY2020 | Jun 30, 2020 | -13.6% | −0.8 |
| Q1 FY2020 | Mar 31, 2020 | -15.2% | +18.9 |
| Q4 FY2019 | Dec 31, 2019 | -2.4% | −2.4 |
| Q3 FY2019 | Sep 30, 2019 | -21.0% | −6.1 |
| Q2 FY2019 | Jun 30, 2019 | -12.8% | −12.8 |
| Q1 FY2019 | Mar 31, 2019 | -34.1% | −6.6 |
| Q4 FY2018 | Dec 31, 2018 | 0.0% | −2.1 |
| Q3 FY2018 | Sep 30, 2018 | -14.9% | +2.7 |
| Q2 FY2018 | Jun 30, 2018 | -0.0% | +20.3 |
| Q1 FY2018 | Mar 31, 2018 | -27.5% | +9.5 |
| Q4 FY2017 | Dec 31, 2017 | 2.1% | +13.1 |
| Q3 FY2017 | Sep 30, 2017 | -17.6% | +16.3 |
| Q2 FY2017 | Jun 30, 2017 | -20.3% | – |
| Q1 FY2017 | Mar 31, 2017 | -37.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -11.0% | – |
| Q3 FY2016 | Sep 30, 2016 | -33.9% | – |
See a number that looks wrong?